Prognostic Surveillance
Prognostic Surveillance is a tumor surveillance framework that systematically monitors clinical and molecular indicators over time to stratify patients by predicted disease outcome, distinguishing itself through its focus on longitudinal assessment of biomarkers and risk factors to guide personalized intervention strategies.
78
Publications
4.7K
Citations
661
Authors
296
Institutions
Publications per year
2017–2026
37
Parents
78
John S. Lam, Oleg Shvarts, John T. Leppert et al. · The Journal of Urology · 2005 · 318 citations
Francisco Rodríguez‐Moranta, Joan Saló, Àngels Arcusa et al. · Journal of Clinical Oncology · 2005 · 298 citations
Prognostic signs and the management of the mycosis fungoides
Zvi Fuks, Malcolm A. Bagshaw, Eugene M. Farber · Cancer · 1973 · 199 citations
1–5 of 78
661
2
h-index
2
h-index
2
h-index
2
h-index
University of California, Los Angeles, United States
2 publications · 346 citations
2
h-index
1–5 of 661
296
Stanford University
Stanford, United States
3 h-index
5 publications
698 citations
Vanderbilt University Medical Center
Nashville, United States
3 h-index
7 publications
350 citations

Sun Yat-sen University
Guangzhou, China
3 h-index
26 publications
551 citations
Hospital for Sick Children
Toronto, Canada
3 h-index
8 publications
128 citations
Mayo Clinic in Florida
Jacksonville, United States
3 h-index
8 publications
497 citations
Inserm
Paris, France
3 h-index
6 publications
162 citations
Northwestern University
Evanston, United States
3 h-index
3 publications
160 citations
University Health Network
Toronto, Canada
2 h-index
3 publications
165 citations
1–8 of 296
4 publications · 592 citations
4
h-index
3 publications · 404 citations
3
h-index
3 publications · 932 citations
3
h-index
Repository · 3 publications · 138 citations
3
h-index
3 publications · 111 citations
3
h-index
1–5